Fundraising FoxChaperone Therapeutics
Chapel Hill, US · Delaware corporation
Find your way into Chaperone Therapeutics
Sign up to see every warm intro you have to Chaperone Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Chaperone Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Chaperone Therapeutics develops therapies targeting protein misfolding diseases, including neurodegenerative and rare conditions, using small molecule drug discovery platforms that enhance natural protein folding mechanisms.
Founders & leadership
Reported raises · per SEC filings
Form D private placements$456.6K disclosed across 1 round · 2016
▶$456.6KraisedJan 2017 · 5 investors · Other Health CareRule 506(b)
- Kalpana MerchantExecutive Officer
- Dennis ThieleExecutive Officer, Director
- Maria Sippola-ThieleExecutive Officer, Director, Promoter
- Offering amount
- $900K
- Amount sold
- $456.6K
- First sale
- Dec 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 1
Companies working in the same space as Chaperone Therapeutics.
Non-dilutive funding · 2 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2017 | $3M |
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2016 | $270K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Chaperone Therapeutics do?
- Chaperone Therapeutics develops therapies targeting protein misfolding diseases, including neurodegenerative and rare conditions, using small molecule drug discovery platforms that enhance natural protein folding mechanisms.
- How much funding has Chaperone Therapeutics raised?
- Chaperone Therapeutics has disclosed $456.6K raised across 1 round.
- Where is Chaperone Therapeutics headquartered?
- Chaperone Therapeutics is headquartered in Chapel Hill, US.